These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7812092)

  • 41. The T cell response to the glycoprotein D of the herpes simplex virus: the significance of antigen conformation.
    Heber-Katz E; Hollosi M; Dietzschold B; Hudecz F; Fasman GD
    J Immunol; 1985 Aug; 135(2):1385-90. PubMed ID: 2409148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protection against ocular and cutaneous infection with herpes simplex virus type 1 by intragastric immunization with live virus.
    Irie H; Shimeld C; Williams N; Hill T
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1357-62. PubMed ID: 8393076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of glycoprotein D of herpes simplex virus type 1 in a recombinant baculovirus: protective responses and T cell recognition of the recombinant-infected cell extracts.
    Krishna S; Blacklaws BA; Overton HA; Bishop DH; Nash AA
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1805-14. PubMed ID: 2544667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute and latent herpes simplex virus neurological disease in mice immunized with purified virus-specific glycoproteins gB or gD.
    Dix RD; Mills J
    J Med Virol; 1985 Sep; 17(1):9-18. PubMed ID: 2995573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The effect of immunization with herpes simplex virus glycoprotein D fused with interluekin-2 against murine herpetic keratitis].
    Inoue T; Inoue Y; Nakamura T; Yoshida A; Inoue Y; Tano Y; Shimomura Y; Fujisawa Y; Aono A; Hayashi K
    Nippon Ganka Gakkai Zasshi; 2001 Apr; 105(4):223-9. PubMed ID: 11329945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunomodulation of experimental murine herpes simplex keratitis: II. Glycoprotein D protection.
    Foster CS; Sandstrom IK; Wells PA; Thompson P; Daigle J; Opremcak EM
    Curr Eye Res; 1988 Nov; 7(11):1051-61. PubMed ID: 2854037
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MHC-II but not MHC-I responses are required for vaccine-induced protection against ocular challenge with HSV-1.
    Ghiasi H; Cai S; Nesburn AB; Wechsler SL
    Curr Eye Res; 1997 Nov; 16(11):1152-8. PubMed ID: 9395776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide.
    Avery AC; Zhao ZS; Rodriguez A; Bikoff EK; Soheilian M; Foster CS; Cantor H
    Nature; 1995 Aug; 376(6539):431-4. PubMed ID: 7630419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytotoxic T lymphocytes. Their relevance in herpesvirus infections.
    Martin S; Cantin E; Rouse BT
    Ann N Y Acad Sci; 1988; 532():257-72. PubMed ID: 2845846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Topical administration of HSV gD-IL-2 DNA is highly protective against murine herpetic stromal keratitis.
    Inoue T; Inoue Y; Hayashi K; Yoshida A; Nishida K; Shimomura Y; Fujisawa Y; Aono A; Tano Y
    Cornea; 2002 Jan; 21(1):106-10. PubMed ID: 11805518
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Previous immunization of mice with herpes simplex virus type-1 strain MP protects against secondary corneal infection.
    Sandstrom IK; Foster CS; Wells PA; Knipe D; Caron L; Greene MI
    Clin Immunol Immunopathol; 1986 Aug; 40(2):326-34. PubMed ID: 3013476
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lyt-1+ T cells participate in recovery from ocular herpes simplex virus type 1 infection.
    Oakes JE; Rector JT; Lausch RN
    Invest Ophthalmol Vis Sci; 1984 Feb; 25(2):188-94. PubMed ID: 6321384
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Herpetic stromal keratitis in the absence of viral antigen recognition.
    Banerjee K; Deshpande S; Zheng M; Kumaraguru U; Schoenberger SP; Rouse BT
    Cell Immunol; 2002 Oct; 219(2):108-18. PubMed ID: 12576029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of immunization with herpes simplex virus glycoprotein D fused with interleukin-2 against murine herpetic keratitis.
    Inoue T; Inoue Y; Nakamura T; Yoshida A; Inoue Y; Tano Y; Shimomura Y; Fujisawa Y; Aono A; Hayashi K
    Jpn J Ophthalmol; 2002; 46(4):370-76. PubMed ID: 12225814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Local periocular vaccination protects against eye disease more effectively than systemic vaccination following primary ocular herpes simplex virus infection in rabbits.
    Nesburn AB; Slanina S; Burke RL; Ghiasi H; Bahri S; Wechsler SL
    J Virol; 1998 Oct; 72(10):7715-21. PubMed ID: 9733807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of different adjuvants on the immune response to a synthetic peptide comprising amino acid residues 9-21 of herpes simplex virus type 1 glycoprotein D.
    Geerligs HJ; Weijer WJ; Welling GW; Welling-Wester S
    J Immunol Methods; 1989 Nov; 124(1):95-102. PubMed ID: 2553820
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunization with dendritic cell-based DNA vaccine pRSC-NLDC145.gD-IL21 protects mice against herpes simplex virus keratitis.
    Tang R; Zhai Y; Dong L; Malla T; Hu K
    Immunotherapy; 2018 Mar; 10(3):189-200. PubMed ID: 29370719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunomodulation of experimental murine herpes simplex keratitis: I. UV-HSV protection.
    Thompson P; Wells PA; Sandstrom IK; Opremcak EM; Millin JA; Daigle JA; Foster CS
    Curr Eye Res; 1988 Nov; 7(11):1043-9. PubMed ID: 2854036
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human T-lymphocyte response in vitro to synthetic peptides of herpes simplex virus glycoprotein D.
    DeFreitas EC; Dietzschold B; Koprowski H
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3425-9. PubMed ID: 2582411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protection from herpes simplex virus type 2 is associated with T cells involved in delayed type hypersensitivity that recognize glycosylation-related epitopes on glycoprotein D.
    Wachsman M; Luo JH; Aurelian L; Paoletti E
    Vaccine; 1992; 10(7):447-54. PubMed ID: 1376951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.